Genetic Test for Breast Cancer Gets FDA Approval

Links shared publicly online about this topic

Ventana Medical receives FDA approval for new breast cancer genetic test

news-medical.net — “The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin, a commonly used breast cancer treatment.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 15, 2011 at 6:36 am By:

NewsMedical News-Medical.Net Health News

Ventana Medical receives FDA approval for new breast cancer genetic test: The U.S. Food and Drug Administration ... http://bit.ly/mrQ99k

11 months ago...

FDA Approves Test That Spots HER2-Positive Breast Cancers - Drugs.com MedNews

drugs.com — “A new genetic test that helps determine if breast cancer patients are good candidates for treatment with the drug Herceptin was approved Tuesday by the U.S. FooView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 14, 2011 at 7:16 pm By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves Test That Spots HER2-Positive Breast Cancers: TUESDAY, June 14 -- A new genetic test that hel... http://bit.ly/jrwVH4 #drug

11 months ago...

FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment

medicalnewstoday.com — “The U.S. Food and Drug Administration approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for HeView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 16, 2011 at 7:05 am By:

mnt_pharma MNT Pharma News Health News and Pharma

FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment http://mnt.to/3XfG

11 months ago...

FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment

medicalnewstoday.com — “The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidatesView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 15, 2011 at 9:30 am By:

vervilledeb1 Debby Verville Health Advocate

FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment: The U.... http://bit.ly/mPxK0p

11 months ago...

Breast and ovarian cancer: Myriad Genetics BRCA1 and BRCA2 gene patents get court approval - latimes.com

latimes.com — “A court of appeals has affirmed patents on the BRCA1 and BRCA2 genes held by Myriad Genetics, which sells tests to determine if people carry the gene variants. BRCA1 and BRCA2 increase a woman's likelihood of developing breast or ovarian cancer.View full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on July 29, 2011 at 10:44 pm By:

Inform Dual ISH HER2 Test Approved for Breast Cancer - ONA

oncologynurseadvisor.com — “The FDA has approved Inform Dual ISH from Ventana Medical Systems, a genetic test to help determine if women with breast cancer are HER2-positive and therefore candidates to receive Herceptin (trastuzumab; Genentech), a HER2 inhibitor.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 14, 2011 at 9:32 pm By:

New Genetic Test Aids Detection of HER2+ Breast Cancer

onclive.com — “On Tuesday the FDA approved a genetic test known as Inform Dual ISH that detects HER2+ breast cancerView full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on June 15, 2011 at 4:48 pm By:

ONClive Editor Oncology

FDA Approves a New Genetic Test for the Detection of HER2+ Breast Cancer http://t.co/2HCQ9Tf

11 months ago...

FDA approves test that identifies Herceptin candidates - ONA

oncologynurseadvisor.com — “A new genetic test that will help health care providers determine whether women with breast cancer are eligible for treatment with trastuzumab (Herceptin) has been approved by the FDA.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 11:32 am By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390